Advanced Solid Tumors Clinical Trials in Aurora, Colorado
5 studies are recruiting for advanced solid tumors in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
The goal of this study is to identify a safe and tolerated dose of the orally administered KIF18A inhibitor ATX-295. In addition, this study will evaluate the pharmacokinetics, pharmacodynamics and preliminary antitumor activity of ATX-295 in patients with advanced solid tumors and ovarian cancer.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- University of Colorado Denver, Aurora, Colorado
- Locations
- 9 in total
- Run by
- Accent Therapeutics
-
A Study of BG-C477 in Participants With Advanced Solid Tumors
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of BG-C477 alone and in combination with anticancer agents in participants with selected advanced solid tumors.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- University of Colorado Cancer Center, Aurora, Colorado
- Locations
- 59 in total
- Run by
- BeOne Medicines
-
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
This is a multicenter, open-label, Phase 1 study. The study will enroll subjects with advanced solid tumors. It consists of six parts. Objectives for Dose-Escalation Parts (Part 1 and Part 4) To evaluate the safety and tolerability of YL211 as monotherapy in patients with selected advanced solid tu…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora, Colorado
- Locations
- 21 in total
- Run by
- MediLink Therapeutics (Suzhou) Co., Ltd.
-
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
The primary goal of this study is to assess the safety and tolerability of mRNA-4359 administered alone and in combination with pembrolizumab or ipilimumab and nivolumab.
- Stage
- Phase 1
- Ages
- 12 and older
- Site
- University of Colorado Cancer Center, Aurora, Colorado
- Locations
- 39 in total
- Run by
- ModernaTX, Inc.
-
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
The purpose of this study is to test the safety and efficacy of BMS-986482 alone and as combination therapy in participants with advanced solid tumors.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Local Institution - 0008, Aurora, Colorado
- Locations
- 21 in total
- Run by
- Bristol-Myers Squibb
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.